Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the combination drug candesartan cilexetil and hydrochlorothiazide by ANI Pharmaceuticals, updating the labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Candesartan Cilexetil and Hydrochlorothiazide (Candesartan cilexetil and hydrochlorothiazide)

Snippet

SUPPL AP for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE)